In a four week, double-blind clinical trial, 20 patients with endogenous depression were randomly assigned to treatment with either viloxazine or imipramine. Statistically significant improvement was observed on the Hamilton Psychiatric Rating Scales for Depression and Anxiety for both treatment groups. There were no differences between the two treatment groups in the type, incidence, or severity of treatment emergent symptoms. No medication-related abnormalities in clinical laboratory values occurred in either treatment group.
|Original language||English (US)|
|Number of pages||2|
|Journal||Journal of Clinical Psychiatry|
|State||Published - May 5 1982|
ASJC Scopus subject areas
- Psychiatry and Mental health